
Metmik P 2mg/500mg/15mg Tablet
Marketer
Mikayla Life Sciences Pvt. Ltd.
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Metmik P 2mg/500mg/15mg Tablet
Glucotrio 2mg/500mg/15mg tablets combine medications to manage blood glucose. This regimen, alongside diet and exercise, enhances blood sugar control in adult type 2 diabetics. It facilitates efficient insulin use, consequently reducing blood sugar. Adhere strictly to your physician's prescribed dosage and duration for Glucotrio 2mg/500mg/15mg tablets; take with food to minimize stomach discomfort. For missed doses, take immediately unless nearing the next scheduled dose; then, omit the missed dose and resume your usual schedule. Never double the dose. Excessive intake may cause hypoglycemia (low blood sugar). Concurrent use with other diabetes medications, alcohol, or skipped meals may increase hypoglycemia risk. Regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be conducted before treatment begins. Limit alcohol consumption to reduce the likelihood of adverse reactions.
Uses of Metmik P 2mg/500mg/15mg Tablet
Managing type 2 diabetes
Major Benefits of Metmik P 2mg/500mg/15mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Metmik P 2mg/500mg/15mg tablet with a meal.
Common Side effects of Metmik P 2mg/500mg/15mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Metmik P 2mg/500mg/15mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Metmik P 2mg/500mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Administer this medication with a meal.
How Metmik P 2mg/500mg/15mg Tablet works:
Metmik P 2mg/500mg/15mg tablets combine glimepiride, metformin, and pioglitazone—three antidiabetic agents with distinct actions—to optimize blood glucose management when monotherapy or dual therapy proves inadequate. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, retarding intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metmik P 2mg/500mg/15mg tablets with alcohol is hazardous.
PregnancyCONSULT YOUR DOCTOR
Using Metmik P 2mg/500mg/15mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against potential hazards prior to prescribing. Seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
The use of Metmik P 2mg/500mg/15mg tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar irregularities.
KidneyCAUTION
Patients with kidney impairment should use Metmik P 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Metmik P 2mg/500mg/15mg tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. Metmik P 2mg/500mg/15mg tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Metmik P 2mg/500mg/15mg Tablet :
Should you forget to take your Metmik P 2mg/500mg/15mg Tablet, administer it immediately. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Metmik P 2mg/500mg/15mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
